Your path in the tree: Start > Economic Development Technological Change, and Growth > Technological Change: Choices and Consequences > Technology Assessment > Health Technology Assessment
This entry's rating: 5/5 (1 ratings)
Log in to rate or make a suggestion

Health Technology Assessment

Narrower topics in the RePEc Biblio tree

This RePEc Biblio topic is edited by Maria João Maia. It was first published on 2013-06-02 14:06:03 and last updated on 2015-03-02 08:35:24.

Introduction by the editor

Health Technology Assessment (HTA) is a multidisciplinary field of analysis and decision, which studies the implications of clinical, social, ethical and economic development, dissemination and use of health technologies (drugs, biologics, devices, equipment, supplies, medical and surgical procedures, support systems, and organizational and managerial systems). The main purpose of HTA is to inform decision making in health care, including decisions made at the individual or patient level, the level of the health care provider or institution, or the regional, national and international levels. HTA is conducted by interdisciplinary groups using explicit analytical frameworks and drawing from a variety of methods.

Most relevant link for this topic

http://technology-assessment.info/index.php/publications

Most relevant JEL codes

Most relevant NEP reports

NEP reports are email or RSS notifications about new research in selected fields. Subscriptions are free.

Most relevant research

  1. Velasco Garrido, Marcial & Gerhardus, Ansgar & Røttingen, John-Arne & Busse, Reinhard, 2010. "Developing Health Technology Assessment to address health care system needs," Health Policy, Elsevier, vol. 94(3), pages 196-202, March.
  2. H. Sigmund & F. B. Kristensen, 2002. "Does health technology assessment benefit health services and politics?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 3(1), pages 54-58, March.
  3. May, Carl & Mort, Maggie & Williams, Tracy & Mair, Frances & Gask, Linda, 2003. "Health technology assessment in its local contexts: studies of telehealthcare," Social Science & Medicine, Elsevier, vol. 57(4), pages 697-710, August.
  4. Maria João Maia, 2011. "Decision-making process in radiology: the magnetic resonance example in the TA context," Enterprise and Work Innovation Studies, Universidade Nova de Lisboa, IET/CICS.NOVA-Interdisciplinary Centre on Social Sciences, Faculty of Science and Technology, vol. 7(7), pages 75-101, November.
  5. Hailey, David, 1997. "Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies," Social Science & Medicine, Elsevier, vol. 45(4), pages 563-581, August.
  6. Gauvin, Francois-Pierre & Abelson, Julia & Giacomini, Mita & Eyles, John & Lavis, John N., 2010. ""It all depends": Conceptualizing public involvement in the context of health technology assessment agencies," Social Science & Medicine, Elsevier, vol. 70(10), pages 1518-1526, May.
  7. RePEc:dau:papers:123456789/13723 is not listed on IDEAS
  8. Josie Messina & David Grainger, 2012. "A Pilot Study to Identify Areas for Further Improvements in Patient and Public Involvement in Health Technology Assessments for Medicines," The Patient: Patient-Centered Outcomes Research, Springer;Johns Hopkins Bloomberg School of Public Health, vol. 5(3), pages 199-211, September.
  9. Hailey, David, 1997. "Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies," Social Science & Medicine, Elsevier, vol. 45(4), pages 563-581, August.
  10. Ciani, Oriana & Tarricone, Rosanna & Torbica, Aleksandra, 2012. "Diffusion and use of health technology assessment in policy making: What lessons for decentralised healthcare systems?," Health Policy, Elsevier, vol. 108(2), pages 194-202.
  11. Linda Davies & Mike Drummond & Panos Papanikoloau, 1999. "Prioritising investments in health technology assessment: can we assess the potential value for money?," Working Papers 170chedp, Centre for Health Economics, University of York.
  12. Oortwijn, Wija & Mathijssen, Judith & Banta, David, 2010. "The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries," Health Policy, Elsevier, vol. 95(2-3), pages 174-184, May.
  13. Elizabeth Fenwick & Karl Claxton & Mark Sculpher & Andrew Briggs, 2000. "Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling," Working Papers 179chedp, Centre for Health Economics, University of York.
  14. Banta, H. David & Vondeling, Hindrik, 1994. "Strategies for successful evaluation and policy-making toward health care technology on the move: The case of medical lasers," Social Science & Medicine, Elsevier, vol. 38(12), pages 1663-1674, June.
  15. Drummond, Michael, 1994. "Evaluation of health technology: Economic issues for health policy and policy issues for economic appraisal," Social Science & Medicine, Elsevier, vol. 38(12), pages 1593-1600, June.
  16. Stern, S. & Trajtenberg, M., 1998. "Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," Papers 24-98, Tel Aviv.
  17. Golan, Ofra & Hansen, Paul & Kaplan, Giora & Tal, Orna, 2011. "Health technology prioritization: Which criteria for prioritizing new technologies and what are their relative weights?," Health Policy, Elsevier, vol. 102(2), pages 126-135.
  18. Ozieranski, Piotr & McKee, Martin & King, Lawrence, 2012. "The politics of health technology assessment in Poland," Health Policy, Elsevier, vol. 108(2), pages 178-193.
  19. Maria João Maia, 2012. "Technology governance in radiology: the example of magnetic resonance imaging," IET Working Papers Series 02/2012, Universidade Nova de Lisboa, IET/CICS.NOVA-Interdisciplinary Centre on Social Sciences, Faculty of Science and Technology.
  20. Allen, Nicola & Pichler, Franz & Wang, Tina & Patel, Sundip & Salek, Sam, 2013. "Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems," Health Policy, Elsevier, vol. 113(3), pages 305-312.